Savita Rangarajan, MD, FRCP, FRCPath

Associate Professor of Clinical Haematology
Faculty of Medicine, University of Southampton, Southampton, UK

Dr Savita Rangarajan is an Associate Professor of Clinical Haematology at the University of Southampton. She is known for her expertise in Coagulation Medicine and in particular has been PI in many Clinical Trials in Haemophilia and other Bleeding disorders. Her particular interest is in changing the management paradigm of these conditions in LMICs and to bring about capacity and capability in Gene & Cell Therapy to India and LMICs.

Presentation(s):

• OC 21.6 - Gene Therapy III

  Sunday, July 10, 2022
  2:45 PM – 4:00 PM

• OC 21.2 - Hemostatic results for up to 6 years following treatment with valoctocogene roxaparvovec, an AAV5-hFVIII-SQ gene therapy for severe hemophilia A

  Sunday, July 10, 2022
  3:00 PM – 3:15 PM

• OC 40.5 - Crimson 1: A Phase 3 study to evaluate the efficacy and safety of subcutaneous marzeptocog alfa (activated) for on-demand treatment of bleed events in subjects with hemophilia A or B, with inhibitors

  Monday, July 11, 2022
  3:45 PM – 4:00 PM

• SSC 13.14 - Q&A

  Monday, July 11, 2022
  6:24 PM – 6:30 PM

• OC 50.2 - Fitusiran, an Investigational siRNA Therapeutic Targeting Antithrombin: Analysis of Antithrombin Levels and Thrombin Generation from a Phase 3 Study in People with Hemophilia A or B Without inhibitors

  Tuesday, July 12, 2022
  11:00 AM – 11:15 AM

• PB1152 - Fitusiran, an Investigational siRNA Therapeutic Targeting Antithrombin: Analysis of Antithrombin Levels and Thrombin Generation from a Phase 3 Study in People with Hemophilia A or B With Inhibitors

  Tuesday, July 12, 2022
  6:30 PM – 7:30 PM